Health Invest Partners Ab Gilead Sciences, Inc. Transaction History

Health Invest Partners Ab

$161 Million
Q1 2024

A detailed history of Health Invest Partners Ab transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Health Invest Partners Ab holds 52,000 shares of GILD stock, worth $3.56 Million. This represents 2.36% of its overall portfolio holdings.

Number of Shares

52,000

Previous 98,974 47.46%

Holding current value

$3.56 Million

Previous $8.02 Million 52.49%

% of portfolio

2.36%

Previous 6.36%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$71.58 - $87.29 $3.36 Million - $4.1 Million	-46,974 Reduced 47.46%	52,000 $3.81 Million
Q4 2023 Jan 30, 2024	BUY	$73.27 - $83.09 $2.8 Million - $3.18 Million	38,214 Added 62.89%	98,974 $8.02 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $2.76 Million - $3.96 Million	-44,240 Reduced 42.13%	60,760 $5.22 Million
Q3 2022 Oct 21, 2022	BUY	$59.54 - $68.01 $2.8 Million - $3.2 Million	47,000 Added 81.03%	105,000 $6.48 Million
Q2 2022 Jul 08, 2022	SELL	$57.72 - $65.01 $2.31 Million - $2.6 Million	-40,000 Reduced 40.82%	58,000 $3.59 Million

Q1 2022 May 05, 2022	BUY	$57.92 - $72.58 $5.68 Million - $7.11 Million	98,000 New	98,000 $5.83 Million
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $2.05 Million - $2.33 Million	-36,100 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $2.88 Million - $3.38 Million	-40,500 Reduced 52.87%	36,100 $2.59 Million
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $1.51 Million - $1.79 Million	-21,000 Reduced 21.52%	76,600 $6.21 Million
Q2 2017 Aug 07, 2017	BUY	N/A	97,600	97,600 $6.91 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.

Account

Health Invest Partners Ab Gilead Sciences, Inc. Transaction History